title: [Experimental study on the anti-liver fibrosis effect of guzhang tablet in rats].
abstract: OBJECTIVE
  To observe the anti-liver-fibrosis effect of Guzhang Tablet (GZT) and to explore its mechanism.
  
  
  METHODS
  Fifty female rats, weighing 200-220 g were randomly divided into the blank control group, the model group, the small dosage GZT group, the large dosage GZT group and the Biejiajian Pill (BJJP) group, 10 rats in each group. The changes of related serum enzymes, liver-fibrosis marker, oxygen free radical and liver tissue pathology were observed after 8 weeks of treatment.
  
  
  RESULTS
  (1) Compared with the model group, the serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), glutamyltranspetidase (GGT), alkaline phosphatase (AKP) were improved in the GZT groups, better effect was got in the large dosage GZT group. (2) Compared with the blank control group, GZT showed no effect on serum total protein (TP) but with raising albumin (ALB) effect. (3) Compared with blank control group, the levels of hyaluronidase (HA), laminin (LN), collagen type IV (IV-C) and procollagen type III (PC III) in both GZT groups were lower, especially in the large dosage GZT group. (4) Small and large dosage of GZT showed effect in reducing malonyldialdehyde (MDA), Glutathione-peroxidose(GSH-Px) and nitric oxide (NO) content, but the effect on increasing superoxide dismutase (SOD) similar to that of BJJP with no significant different. (5) GZT, both small and large dosage, had obvious anti-liver fibrosis action, which was superior to that of BJJP.
  
  
  CONCLUSIONS
  In the genetic and developing processes of liver fibrosis in rats, GZT could protect the liver cells, inhibit the synthesis and reduce the content of collagens, the mechanism might be related with its action in antagonizing peroxidation injury, indicating that GZT could effectively prevent liver fibrosis formation.
authors.affiliation: Henan Provincial Academy of TCM, Zhengzhou 450004.
authors.forename: Yu-yao
authors.initials: YY
authors.lastname: Zhao
authors.forename: Fang-zhou
authors.initials: FZ
authors.lastname: Liu
authors.forename: Xiao-ping
authors.initials: XP
authors.lastname: Yang
mesh_terms: D000818:Animals; D024061:Collagen Type III / Q000097:blood*; D024141:Collagen Type IV / Q000097:blood*; D004365:Drugs, Chinese Herbal / Q000494:pharmacology* / Q000627:therapeutic use; D006821:Hyaluronoglucosaminidase / Q000097:blood; D007797:Laminin / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood / Q000473:pathology* / Q000517:prevention & control; D008297:Male; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013607:Tablets
chemical_list: D024061:Collagen Type III; D024141:Collagen Type IV; D004365:Drugs, Chinese Herbal; D007797:Laminin; D013607:Tablets; D006821:Hyaluronoglucosaminidase